Retracted: Molecular characterization of excipients' preferential interactions with therapeutic monoclonal antibodies.
J Pharm Pharmacol
; 70(2): 289-304, 2018 Feb.
Article
en En
| MEDLINE
| ID: mdl-28776673
ABSTRACT
Retraction Molecular characterization of excipients' preferential interactions with therapeutic monoclonal antibodies by Jehoon Kim, Mark R. H. Krebs and Bernhardt L. Trout The above article from the Journal of Pharmacy and Pharmacology, first published online on 4 August 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Professor David Jones, and John Wiley & Sons Ltd. The authors discovered that the analysis of simulations was faulty making the data incorrect. Reference Kim J et al. Molecular characterization of excipients' preferential interactions with therapeutic monoclonal antibodies. J Pharm Pharmacol 2017. https//doi.org/10.1111/jphp.12787.
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
J Pharm Pharmacol
Año:
2018
Tipo del documento:
Article
País de afiliación:
Estados Unidos